Clinical Trial Investigator

The National Institutes of Health (NIH) is pleased to offer the annual Stadtman Investigator Program for researchers seeking a tenure-track (assistant professor equivalent) position within its Intramural Research Program (IRP). The program is open to applicants conducting research in any area of biomedical science supported by the NIH. Who we are: The IRP is a research institution whose hallmarks are stable funding, intellectual freedom, shared resources, and access to a wide range of scientific expertise and the world’s largest hospital dedicated to clinical research. It is home for around 1,000 principal investigators, nearly 2,000 other clinical and research faculty members, and more than 4,000 trainees and fellows from the undergraduate to the postdoctoral level. The program is intended for applicants interested in being a principal investigator of a research group advancing the knowledge of living systems and its application to enhance human health while mentoring the next generation of scientists. We seek creative thinkers eager to take on innovative high-impact research.

have a robust record of research accomplishments as evidenced by high quality publications in peer-reviewed journals; S. citizen, resident alien, or non-resident alien with, or eligible to obtain, a valid employment-authorization visa.

Twenty-six different committees, listed below, composed of IRP faculty with scientific expertise in a wide range of fields will review the applications. In the application system, each applicant must choose at least one committee and may choose up to 2 committees that best match their research field.

Biomedical Engineering/Biophysics/Physics

Chemistry/Chemical Biology/Toxicology

Chromosome Biology/Epigenetics/Transcription

Computational Biology/Bioinformatics/Biostatistics/Artificial Intelligence

Developmental Biology

Molecular and Cellular Neuroscience

Molecular Biology

Molecular Pharmacology/Cell Signaling

The review committees will evaluate the applications on research accomplishments as evidenced by published work in peer-reviewed journals, proposed research that addresses an important scientific or public health problem, and potential for success as an independent investigator leading a research group composed mostly of trainees from postbacs to postdocs.

Based on its evaluation, each review committee compiles a short list of the most highly rated applicants who merit further consideration for interviews (roughly 25% of reviewed applications). Applicants will be notified of their status by the end of January.